Bruker, Champalimaud Foundation announce collaboration
Bruker announced an agreement to develop the world's first 18 Tesla 11 cm bore, preclinical ultra-high field magnetic resonance imaging system and its clinical research applications in collaboration with the Champalimaud Foundation. This novel and unique system is expected to enable Champalimaud researchers to advance translational cancer and neuroscience research with UHF MRI and magnetic resonance spectroscopic imaging. The 18T MRI is expected to be installed in late 2021 in the Neuroplasticity and Neural Activity laboratory under Dr. Noam Shemesh, with the goal to develop novel contrast mechanisms in MRI and spectroscopic imaging. The Champalimaud Foundation focuses its research on neuroscience and oncology, and the 18T system will advance the Foundation's in vivo research into cancer, metastasis and pre-metastatic niches in multiple cancer models. It will also advance research into brain plasticity and activity in normal and neurodegenerative disease models.